Irbesartan Comp Basics

Irbesartan/Hydrochlorothiazide, the active ingredient in Irbesartan Comp Basics, is an angiotensin II receptor blocker / thiazide diuretic presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Irbesartan Comp Basics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan Comp Basics is used in the management of hypertension, a condition characterized by elevated arterial pressure. - Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with fluid retention: promotes diuresis to decrease blood volume and pressure. - Hypertension in patients with diabetes: helps control blood pressure while mitigating renal complications.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Acute kidney injury or worsening renal function - Hyperkalemia leading to cardiac arrhythmia - Angioedema involving face, lips, or airway - Significant hypotension causing fainting - Severe allergic reactions such as rash or Stevens‑Johnson syndrome

Patients should be aware of several safety considerations before starting therapy. - Blood pressure monitoring: check regularly to avoid excessive lowering. - Renal function assessment: evaluate serum creatinine and eGFR before and during treatment. - Electrolyte surveillance: monitor potassium and sodium levels, especially with concomitant diuretics. - Pregnancy warning: contraindicated in pregnancy due to fetal toxicity (Category D). - Elderly caution: start at lower doses and monitor for orthostatic hypotension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan Comp Basics can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal impairment and hyperkalemia. - Potassium‑sparing agents or supplements: can cause dangerous hyperkalemia. - Lithium: may raise lithium levels, leading to toxicity. - ACE inhibitors or other ARBs: additive effects on blood pressure and kidney function. - NSAIDs (e.g., ibuprofen): may reduce antihypertensive efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - Other diuretics: may enhance electrolyte loss and dehydration. - CYP2C9 inhibitors (e.g., fluconazole): can increase irbesartan plasma concentrations. - Antihypertensive agents (beta‑blockers, calcium channel blockers): may require dose adjustments to prevent hypotension.